DexCom Inc (DXCM) stock
DXCMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 22/3033% below fair value
$79.32−0.87 (-1.08%)
Close on Nov 20, 2026Market cap $29.58BP/E 31.2Yield –
DexCom shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
DexCom's shares outstanding was 384M at Sep 30, 2026. For fiscal 2025 it was 406M, down 1.7% from the year before. Over ten years it grew 2.4% a year on average. The highest annual figure on record is 429M in fiscal 2021.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 406M | -1.7% |
| FY2024 | Dec 31, 2024 | 413M | -3.0% |
| FY2023 | Dec 31, 2023 | 426M | -0.5% |
| FY2022 | Dec 31, 2022 | 428M | -0.3% |
| FY2021 | Dec 31, 2021 | 429M | +2.0% |
| FY2020 | Dec 31, 2020 | 420M | +13.9% |
| FY2019 | Dec 31, 2019 | 369M | +4.6% |
| FY2018 | Dec 31, 2018 | 353M | +2.2% |
| FY2017 | Dec 31, 2017 | 345M | +3.2% |
| FY2016 | Dec 31, 2016 | 334M | +4.8% |
| FY2015 | Dec 31, 2015 | 319M | +6.1% |
| FY2014 | Dec 31, 2014 | 301M | +5.8% |
| FY2013 | Dec 31, 2013 | 284M | +3.5% |
| FY2012 | Dec 31, 2012 | 275M | +4.7% |
| FY2011 | Dec 31, 2011 | 262M | +15.3% |
| FY2010 | Dec 31, 2010 | 228M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 384M | -5.9% |
| Q2 FY2026 | Jun 30, 2026 | 390M | -4.4% |
| Q1 FY2026 | Mar 31, 2026 | 394M | -3.4% |
| Q4 FY2025 | Dec 31, 2025 | 399M | -1.9% |
| Q3 FY2025 | Sep 30, 2025 | 407M | -0.7% |
| Q2 FY2025 | Jun 30, 2025 | 408M | -2.1% |
| Q1 FY2025 | Mar 31, 2025 | 408M | -2.2% |
| Q4 FY2024 | Dec 31, 2024 | 407M | -2.5% |
| Q3 FY2024 | Sep 30, 2024 | 410M | -3.9% |
| Q2 FY2024 | Jun 30, 2024 | 417M | -3.4% |
| Q1 FY2024 | Mar 31, 2024 | 417M | -0.4% |
| Q4 FY2023 | Dec 31, 2023 | 417M | -2.1% |
| Q3 FY2023 | Sep 30, 2023 | 427M | +0.2% |
| Q2 FY2023 | Jun 30, 2023 | 432M | +2.4% |
| Q1 FY2023 | Mar 31, 2023 | 419M | -2.4% |
| Q4 FY2022 | Dec 31, 2022 | 426M | -1.3% |
| Q3 FY2022 | Sep 30, 2022 | 426M | -1.0% |
| Q2 FY2022 | Jun 30, 2022 | 421M | -1.3% |
| Q1 FY2022 | Mar 31, 2022 | 429M | +2.5% |
| Q4 FY2021 | Dec 31, 2021 | 432M | -16.8% |
| Q3 FY2021 | Sep 30, 2021 | 430M | +8.1% |
| Q2 FY2021 | Jun 30, 2021 | 427M | +10.1% |
| Q1 FY2021 | Mar 31, 2021 | 418M | +11.2% |
| Q4 FY2020 | Dec 31, 2020 | 519M | +40.1% |
| Q3 FY2020 | Sep 30, 2020 | 398M | +7.6% |
| Q2 FY2020 | Jun 30, 2020 | 388M | +6.5% |
| Q1 FY2020 | Mar 31, 2020 | 376M | +4.2% |
| Q4 FY2019 | Dec 31, 2019 | 370M | +9.1% |
| Q3 FY2019 | Sep 30, 2019 | 370M | +2.4% |
| Q2 FY2019 | Jun 30, 2019 | 364M | +1.9% |
| Q1 FY2019 | Mar 31, 2019 | 361M | +3.4% |
| Q4 FY2018 | Dec 31, 2018 | 340M | -2.3% |
| Q3 FY2018 | Sep 30, 2018 | 361M | +4.2% |
| Q2 FY2018 | Jun 30, 2018 | 358M | +2.3% |
| Q1 FY2018 | Mar 31, 2018 | 349M | +2.5% |
| Q4 FY2017 | Dec 31, 2017 | 348M | +2.8% |
| Q3 FY2017 | Sep 30, 2017 | 347M | – |
| Q2 FY2017 | Jun 30, 2017 | 350M | – |
| Q1 FY2017 | Mar 31, 2017 | 341M | – |
| Q4 FY2016 | Dec 31, 2016 | 338M | – |
See a number that looks wrong?